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a b s t r a c t
Background: Medically unexplained symptoms (MUSs) are common in primary care. At
present, there are no proven, comprehensive treatments available in primary care for
patients with MUSs. However, MUS has parallels with “subhealth” or Mibyeong from tradi-
tional East-Asian medicine, and thus, Mibyeong interventions could be effective in treating
MUS. Unfortunately, studies on Mibyeong and its intervention methods are relatively rare.
Methods: We administered a web-based survey to 17,279 Korean medicine (KM) practitioners
registered with the Association of Korean Medicine. The response rate was 4.9% (n=849).
Based on the responses received, we assessed how much they agreed with concepts related
to Mibyeong on a 7-point scale from “do not agree” to “strongly agree.” Respondents were
also asked to indicate how frequently they encountered various subtypes and patterns of
Mibyeong, and how frequently they use listed intervention methods.
Results: Data from 818 respondents were analyzed after excluding those with no clinical
experience. On average, respondentsweremale general practitioners aged between 30 years
and 49 years, working or living in metropolitan areas such as Seoul, Incheon, and Gyeonggi-
do. Responses did not differ by demographics. Respondents generally thought that Mibyeong
referred to subjective or borderline ﬁndings without certain disease, and that Mibyeong has
various subtypes andpatterns. Subtypes included fatigue, pain, anddigestionproblems; pat-
terns were either deﬁciencies (e.g., qi, blood, and yin deﬁciency) or stagnations (e.g., liver qi
depression and qi stagnation). Decoction was the most frequently used type of intervention
for Mibyeong of all items listed, followed by acupuncture and moxibustion. Patient educa-
tion was also recommended, suggesting healthy eating, promoting healthy environment,
and exercise.
Conclusion: We were able to provide preliminary results on KM practitioners’ recognition of
and interventions for Mibyeong, but further research is needed to develop a detailed deﬁ-nition of Mibyeong and its myriad subtypes and patterns, and evaluations of the efﬁcacy ofMibyeong interventions.
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. Introduction
omatoform disorders and medically unexplained symptoms
MUSs) are common in primary care. Furthermore, of patients
ho report suffering from fatigue or pain, only 10–15% are
iven a formal diagnosis within a 1-year period.1 The preva-
ence rates for MUS range from 1.6% to 70% in 20–50 year olds,
rom 2.4% to 87% in 50–65 year olds, and from 4.6% to 18%
n people over the age of 65 years.2 Somatoform disorder and
US are generally thought not to result from biological dis-
ases, but rather are more related to mental disorders such as
nxiety and depression.3
Unexplained symptoms can result in decreases in health-
elated quality of life,4 as well as increases in medical costs
ecause of frequent, unnecessary visits to healthcare facilities
or checkups and diagnoses.5 However, there are no proven,
omprehensive treatments currently available in primary care
or patients with MUS. Several studies have suggested that
he combination of collaborative stepped care, cognitive-
ehavioral therapy, and a good provider–patient relationship
ay be effective in relieving symptoms, but this is not consid-
red a standard treatment.6,7
To treat MUS, we suggest using treatments for “subhealth”
r Mibyeong (China: Weibing, Japan: Mibyou) from traditional
ast-Asianmedicine.Mibyeong generally refers to an abnormal
ody conditionwithout certain disease.8 Thus, it is considered
imilar to MUS in “presenting physical and mental symptoms
ithout related disease”; by contrast,Mibyeonghas differences
ith unexplained symptoms or somatoform disorders in to
ntervene symptoms in pattern identiﬁcation.8 Some Korean
edicine (KM) practitioners useMibyeong treatments to relieve
US, although there are no reports on the efﬁcacy of this
ractice. The Huangdi Neijing, an important medical text in
raditional East-Asian medicine, has emphasized that treat-
ng Mibyeong is even more important than curing a disease
hat has already manifested, because Mibyeong implies that
he condition could get worse over time.9 Indeed, Mibyeong
as two different clinical deﬁnitions: (1) symptoms and signs
ithout apparent disease and (2) a high-risk factor for dis-
ase. In general, KM clinics target the ﬁrst deﬁnition. Of the
orean general population, 77.5%have reportedly experienced
sing KM, and 75.6% of KM users have responded that they
rust KM treatments. Furthermore, 12% of KM users are inter-
sted in KM for health promotion and not to cure disease.10
esearch has shown that some KM treatments are effective in
elieving Mibyeong symptoms; for example, acupuncture and
oxibustion appear to relieve chronic fatigue.11,12
However, few studies have been conducted on practition-
rs’ recognition and knowledge aboutMibyeong, or on available
reatmentmethods. To ﬁll this gap, we conducted aweb-based
urvey to describe KM practitioners’ recognition of and inter-
entions for Mibyeong.
. Methods.1. Study population
he studypopulation included17,279members of theAssocia-
ion of Korean Medicine (AKOM) who had their e-mail address61
registered. The AKOM is a national professional organization
for doctors of KM.
2.2. Study design
The survey was conducted after obtaining AKOM’s approval.
The AKOM members were invited to respond to a web-based
questionnaire on Mibyeong concepts and interventions from
April 2013 to May 2013. We excluded the responses of any
practitioner without clinical experience. E-mail invitations for
study participation were sent three times—on April 19, April
26, and May 6. A short message asking practitioners to com-
plete the survey was also sent after the second e-mail.
2.3. Survey instrument
Thequestionnairewas composedof threeparts: (1) eight items
assessing respondents’ recognition of Mibyeong, including
whether it consisted of subtypes and patterns; (2) seven items
assessing intervention methods, including herbal medicine,
acupuncture, and patient education, which are generally used
for Mibyeong in KM clinics10; and (3) eight items on personal
background. Items 1–6 on the recognition ofMibyeong assessed
howmuch practitioners agreedwith various statements about
Mibyeong on a 7-point scale, ranging from “1=do not agree”
to “7= strongly agree.” Items 7 and 8 assessed the frequency
of subtype and pattern for Mibyeong. The items for assessing
respondents’ knowledge of the concepts and their recogni-
tion of Mibyeong were as follows: (1) Mibyeong can be deﬁned
as uncomfortable symptoms without apparent disease; (2)
Mibyeong refers to subjective symptoms, including fatigue,
pain, sleep disorder, and digestive problems, that have no for-
mal diagnosis by Western medicine; (3) the clinical deﬁnition
of Mibyeong is “borderline ﬁndings without speciﬁc symp-
toms”; (4) Mibyeong could be classiﬁed into subtypes based on
the exhibited condition and severity; (5) subtypes of Mibyeong
are fatigue, pain, sleep, digestive problems, and borderline
ﬁndings; (6) the pattern/syndrome identiﬁcation can be used
to classify Mibyeong; (7) what are the frequent subtypes of
Mibyeong in KM clinic?; and (8) what are the frequent patterns
of Mibyeong in KM clinic?
Respondents were asked to choose their three most fre-
quently used interventions for each of the seven items.
All items were constructed with the collaboration of three
researchers, and were assessed and revised by other KM
experts at four separate meetings.
2.4. Statistical analysis
Descriptive statistics, which aremean and standard deviation,
were calculated for all variables. We calculated the num-
ber of respondents who chose a given answer for each item.
Continuous variables were compared using the independent
two-sample t test and one-way analysis of variance with a post
hoc Scheffé’s test. All statistical analyseswere performedusing
IBM SPSS Statistics 21 (IBM Corp., Armonk, New York, USA) for
Windows and p<0.05 were considered statistically signiﬁcant.
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Seoul, Incheon, and Gyeonggi-do 408 (50)
Gangwon-do 22 (3)
Chungcheong Province 101 (12)
Jeolla Province 94 (11)
Gyeongsang Province 193 (24)
Specialties *
General practitioner † 633 (77)
Specialist ‡ 167 (20)
Board certiﬁcation § 33 (4)
Data are presented as n (%).
* Specialist and Board certiﬁcation could overlap.
† General practitioner, Doctors of Korean Medicine who did not take
training course in hospital nor have Border Certiﬁcation from Aca-
demic Societies or Association of Korean Medicine.
‡ Specialist, Doctors of Korean Medicine who usually further their
medical education in a speciﬁc specialty of medicine by completing
a multiple year residency after completing Korean medical school.
There are eight specialties in Korea.
§ Border Certiﬁcation, Doctors of Korean Medicine who are qualiﬁed
to perform speciﬁc technique. It is certiﬁed by Academic Societies
or Association of Korean Medicine.
3. Results
3.1. Respondent demographics
Of the 17,729 invited participants, 884 opened the survey
e-mail, whereas 847 (4.9%) completed the survey during
the data-collection period. Among the 847 respondents, 29
answered that they had no clinical experience, and therefore,
we excluded their responses from analysis. Thus, we ana-
lyzed data from a total of 818 respondents. On average, survey
respondents were male general practitioners aged between 30
years and 49 years, working or living in metropolitan areas
including Seoul, Incheon, and Gyeonggi-do (Table 1).
3.2. Recognition of Mibyeong
Participants generally agreed with presented items on their
recognition of Mibyeong. We found no signiﬁcant differences
by demographic characteristics in agreement on items, except
between general practitioners and specialists on Items 3 and 4
(Item 3=The clinical deﬁnition of Mibyeong is borderline ﬁnd-
ings without speciﬁc symptoms; Item 4=Mibyeong could be
classiﬁed into subtypes in terms of exhibited condition and
severity) with specialists being less likely to agree for both
items; however, the difference, although signiﬁcant, does notIntegr Med Res ( 2 0 1 4 ) 60–66
indicate the opposite meaning between general practitioners
and specialists. In other words, most participants agreed that
Mibyeong was borderline ﬁndings without speciﬁc symptoms,
and that Mibyeong had speciﬁc subtypes (Table 2).
3.3. Subtypes, patterns, and interventions for
Mibyeong
Table 3 displays respondents’ chosen answers for the most
frequently encountered subtypes and patterns, and the most
frequently used interventions. Over half of the respondents
indicated that “fatigue”was observed as a subtype ofMibyeong;
for the second and third most frequent subtypes, a similar
number of respondents listed “digestive problems.” Pain had
the second highest proportion of responses (ranked two), fol-
lowed by “sleep disorders” (ranked three).
A total of 45.1% of participants listed “qi deﬁciency” as
the frequent pattern of Mibyeong, followed by “blood deﬁ-
ciency” and “yin deﬁciency.” However, the responses for the
patterns of Mibyeong are somewhat more scattered than for
the subtypes, and therefore, the proportions of responses
for other items were high. For the interventions, we ﬁrst
examined them as groups, followed by individual interven-
tion methods within those groups. In the group analysis,
participants answered “decoction” was the most important
intervention, with nearly 60% of responses. Acupuncture ther-
apywas ranked second (36.1% response rate) andmoxibustion
was ranked third (21.8% response rate).
With regard to individual interventions by group, the
herbal drug product Bojungikgi-tang (bu-zhong-yi-qi-tang) had
the highest proportion of responses for all three rank-
ings. Sipjeondaebo-tang (Shi-quan-da-bu-tang), Gwibi-tang (gui-
pi-tang), and Ssanghwa-tang (shuang-hua-tang) also had high
frequencies of use.
For herbs, Ginseng radix had the highest proportion of
responses for all three rankings. The other herbs—Cervi
parvum cornu, radix astragali, radix rehmanniae preparata, and
angelicae gigantis radix—each had over 10% of responses.
For acupuncture, the response rate of “common acupunc-
ture” was 52.3%. “Saam acupuncture” and “Dong’s acupunc-
ture” were the second and third most frequently used
intervention methods, respectively. For the herbal acupunc-
ture, we found that bee venom had the highest proportion of
responses for all three rankings, although none of the inter-
ventions had more than 40% of responses for any ranking.
For physical therapy, 45.6% of participants answered that
infrared therapy was used for Mibyeong intervention, followed
by hot packs and interferential current therapy as the second
and third most frequently used interventions, respectively.
Finally, for patient education, healthy eating was recom-
mend by 63.1% of participants, followed by promotion of
environmental health and exercise as the second and third
most frequently used interventions, respectively.
4. DiscussionIn this study,weaimed todescribe the recognition of and inter-
ventions for Mibyeong in KM practitioners. Respondents did
not generally differ in their recognition of Mibyeong, although
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Table 2 – Respondents’ recognition of Mibyeong compared by demographics.
Characteristic Item 1* Item 2† Item 3‡ Item 4§ Item 5|| Item 6¶
Gender
Male 5.48 (1.56) 5.65 (1.47) 4.78 (1.66) 4.99 (1.3) 4.97 (1.48) 5.82 (1.43)
Female 5.57 (1.38) 5.56 (1.44) 5.02 (1.61) 5.1 (1.3) 4.96 (1.49) 5.81 (1.36)
Age (y)
Below 40 5.44 (1.45) 5.61 (1.41) 4.81 (1.59) 5.02 (1.25) 4.9 (1.44) 5.78 (1.39)
40–49 5.58 (1.58) 5.68 (1.51) 4.77 (1.71) 5.04 (1.34) 5.04 (1.53) 5.94 (1.44)
Over 50 5.45 (1.65) 5.6 (1.53) 5 (1.7) 4.89 (1.37) 5 (1.49) 5.62 (1.47)
Number of years in practice
1–10 5.48 (1.49) 5.55 (1.51) 4.83 (1.6) 5.02 (1.27) 4.96 (1.46) 5.8 (1.41)
11+ 5.51 (1.58) 5.73 (1.41) 4.81 (1.71) 4.99 (1.34) 4.98 (1.5) 5.85 (1.44)
Region
Seoul, Incheon, and Gyeonggi-do 5.51 (1.56) 5.72 (1.45) 4.87 (1.68) 5.03 (1.36) 4.95 (1.52) 5.88 (1.4)
Gangwon-do 5.23 (1.72) 5.64 (1.68) 4.18 (1.53) 4.91 (1.23) 5.14 (1.52) 5.27 (1.93)
Chungcheong Province 5.55 (1.4) 5.53 (1.45) 4.74 (1.62) 4.97 (1.27) 4.88 (1.47) 5.86 (1.2)
Jeolla Province 5.4 (1.48) 5.66 (1.43) 5.01 (1.51) 4.95 (1.31) 5.02 (1.4) 5.62 (1.55)
Gyeongsang Province 5.51 (1.56) 5.5 (1.49) 4.74 (1.68) 5.01 (1.22) 5.01 (1.45) 5.84 (1.44)
Specialties
General Practitioner 5.5 (1.55) 5.65 (1.49) 4.89 (1.63) ** 5.01 (1.32) 5.03 (1.48) ** 5.85 (1.44)
Specialist 5.44 (1.45) 5.6 (1.38) 4.53 (1.71) 4.93 (1.23) 4.71 (1.46) 5.66 (1.4)
Total 5.5 (1.53) 5.63 (1.46) 4.82 (1.65) 5.01 (1.3) 4.97 (1.48) 5.82 (1.42)
Data are presented as mean (standard deviation).
* Item 1, Mibyeong can be deﬁned as uncomfortable symptoms without apparent disease.
† Item 2, Mibyeong refers to subjective symptoms including fatigue, pain, sleep disorder, and digestive problems without a formal diagnosis by
Western Medicine.
‡ Item 3, The clinical deﬁnition of Mibyeong is borderline ﬁndings without speciﬁc symptoms.
§ Item 4, Mibyeong could be classiﬁed into subtypes in terms of exhibited condition and severity.
|| Item 5, Subtypes of Mibyeong are fatigue, pain, sleep, digestive problems, and borderline ﬁndings.




























eneral practitioners and specialists signiﬁcantly differed on
tem 3 (the clinical deﬁnition of Mibyeong is borderline ﬁnd-
ngs without speciﬁc symptoms) and Item 4 (Mibyeong could
e classiﬁed into subtypes in terms of exhibited condition and
everity). This difference may result from the patient popula-
ions they typically care for. Evidence to support this comes
rom other web-based surveys in which practitioner groups
ere divided by major patients they care for and were found
o vary in their recognition of Mibyeong.13,14 In this study, the
ack of difference suggests that KM practitioners’ recognition
f Mibyeong was not based on their background.
Respondents agreed that Mibyeong is not a disease based
olely in Western medicine, but is rather a borderline ﬁnd-
ng. Because South Korea uses a combination of Western
edicine and KM, KM practitioners must often use the West-
rn medicine concepts when diagnosing diseases.
Mibyeong subtypes included fatigue, pain, and other symp-
oms. Fatigue is the most common symptom of Mibyeong in
M clinics. In addition, there are several symptoms or sub-
ypes in Mibyeong, and fatigue could be described as the main
ymptom of Mibyeong. Fatigue without disease has also been
eported in primary care. Reports suggest that 8.4% of primary
are users have chronic fatigue; of this group, 42.9% of patients
an be formally diagnosed. Furthermore, the prevalence of
atigue-speciﬁc disease is relatively rare; the prevalence rate of
15hronic fatigue syndrome is below 1%, and that of hypothy-
oidism is 3.8–4.6%.16 Deﬁciencies were the most frequent
atterns, followed by stagnation (e.g., “liver qi depression”
nd “qi stagnation”). Deﬁciencies typically feature exhaustionand decreased bodily functions, and are contextually related
to fatigue. However, complaints of fatigue by itself are not
directly connected to a diagnosis of deﬁciency patterns. For
example, patients with high fever and constipation complain
of fatigue as a chief symptom, which could be diagnosed as
heat or excess pattern. By contrast, gaunt female patients
with recurring fever andperspirationhaveheat pattern,which
could mean deﬁciency with heat pattern. To identify the pat-
terns clearly, we must consider symptoms as a whole aspect
taking body shape, gender, etc. into account. Stagnation gen-
erally refers to psychological symptoms, such asmental stress
and low mood. As with treating MUS, KM practitioners believe
that physical symptoms and psychological factors are related,
and therefore, relieving mental stress would be one method
of curing patients.
The highest proportion of respondents rated “decoction,”
as the most important intervention, whereas herbal drug
products were much lower. This is interesting, given that
both interventions use herbal compounds. However, it can
be explained by how the use of herbal drug products is
decreasing in KM hospitals and clinics.10 Bojungikgi-tang
(bu-zhong-yi-qi-tang), Sipjeondaebo-tang (Shi-quan-da-bu-tang),
and Ssanghwa-tang (shuang-hua-tang) are toniﬁcation pre-
scriptions, whereas Gwibi-tang (gui-pi-tang) is used to treat
psychological problems related to sleep disorders and stress.
Research on these products is relatively rare, but studies have
reported that Bojungikgi-tang (bu-zhong-yi-qi-tang) can relieve
fatigue from cancer,17 and Sipjeondaebo-tang (Shi-quan-da-bu-
tang) can inﬂuence hemoglobin recovery.18 Herbs also had
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Table 3 – Mibyeong’s subtypes, patterns, and interventions.







Fatigue 530 (64.8) 157 (19.2) 98(12)
Pain 169 (20.7) 231 (28.2) 143 (17.5)
Digestion 67 (8.2) 269 (32.9) 283 (34.6)
Abnormal ﬁndings 25 (3.1) 42 (5.1) 105 (12.8)
Sleeping 19 (2.3) 106(13) 174 (21.3)
No response 8(1) 13 (1.6) 15 (1.8)
Pattern/Syndrome
Qi deﬁciency 369 (45.1) 78 (9.5) 38 (4.6)
Liver qi depression 73 (8.9) 51 (6.2) 77 (9.4)
Qi stagnation 66 (8.1) 101 (12.3) 36 (4.4)
Deﬁciency 48 (5.9) 27 (3.3) 43 (5.3)
Phlegm 35 (4.3) 43 (5.3) 58 (7.1)
Yin deﬁciency 26 (3.2) 43 (5.3) 88 (10.8)
Blood deﬁciency 25 (3.1) 161 (19.7) 57(7)
Other (28 items) 144 (17.6) 261 (31.9) 357 (43.6)
No response 32 (3.9) 53 (6.5) 64 (7.8)
Interventions
Decoction 487 (59.5) 136 (16.6) 163 (19.9)
Acupuncture 255 (31.2) 295 (36.1) 150 (18.3)
Herbal drug products 23(2.8) 143 (17.5) 110 (13.4)
Moxibustion 21 (2.6) 151 (18.5) 178 (21.8)
Other (4 items) 26 (3.2) 81 (9.9) 186 (22.7)
No response 6 (0.7) 12 (1.5) 31 (3.8)
Herbal prescriptions
Bojungikgi-tang (bu-zhong-yi-qi-tang) 190 (23.2) 92 (11.2) 73 (8.9)
Sipjeondaebo-tang(Shi-quan-da-bu-tang) 76 (9.3) 80 (9.8) 52 (6.4)
Gwibi-tang (gui-pi-tang) 61 (7.5) 59 (7.2) 61 (7.5)
Ssanghwa-tang (shuang-hua-tang) 46 (5.6) 83 (10.1) 63 (7.7)
Other (22 items) 437 (53.4) 470 (57.5) 522 (63.8)
No response 8 (1) 34 (4.2) 47 (5.7)
Herb
Ginseng radix 162 (19.8) 141 (17.2) 94 (11.5)
Cervi parvum cornu 153 (18.7) 54 (6.6) 68 (8.3)
Radix astragali 82 (10) 64 (7.8) 58 (7.1)
Radix rehmanniae preparata 60 (7.3) 84 (10.3) 70 (8.6)
Angelicae gigantis radix 58 (7.1) 102 (12.5) 73 (8.9)
Other (29 items) 287 (35.1) 341 (41.7) 410 (50.1)
No response 16 (2) 30 (3.7) 43 (5.3)
Acupuncture theory
Common acupuncture 428 (52.3) 201 (24.6) 159 (19.4)
Saam acupuncture 203 (24.8) 217 (26.5) 94 (11.5)
Herbal acupuncture 38 (4.6) 121 (14.8) 90 (11)
Dong’s acupuncture 20 (2.4) 64 (7.8) 115 (14.1)
Other (7 items) 112 (13.7) 159 (19.4) 265 (32.4)
No response 17 (2.1) 56 (6.8) 95 (11.6)
Herbal acupuncture
Bee venom 179 (21.9) 131 (16) 78 (9.5)
Placenta 107 (13.1) 115 (14.1) 61 (7.5)
Cultivated wild ginseng 66 (8.1) 37 (4.5) 57 (7)
Ba gang 44 (5.4) 62 (7.6) 70 (8.6)
Other (2 items) 95 (11.6) 87 (10.6) 114 (13.9)
No response 327 (40) 386 (47.2) 438 (53.5)
Physical therapy
Infrared 373 (45.6) 168 (20.5) 111 (13.6)
Hot Pack 216 (26.4) 250 (30.6) 97 (11.9)
Interferential current therapy 57 (7) 106 (13) 157 (19.2)
Transcutaneous electrical nerve stimulation 25 (3.1) 81 (9.9) 113 (13.8)
Other 97 (11.9) 148 (18.1) 250 (30.6)
No response 50 (6.1) 65 (7.9) 90(11)
Patient education
Healthy eating 516 (63.1) 183 (22.4) 78 (9.5)
Promoting environmental health 110 (13.4) 263 (32.2) 107 (13.1)
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Table 3 (Continued)






Exercise 84 (10.3) 222 (27.1) 280 (34.2)











































rNo response 12 (1.5)
Data are presented as n (%).
igh response rates; G. radix and C. parvum cornu are com-
on qi-tonifying herbs, whereas radix rehmanniae preparata
nd angelicae gigantis radix are blood-tonifying herbs. These
erbs also make up some of the drug products used in
M.
Compared with herbal prescriptions, nonherbal interven-
ions such as acupuncture, herbal acupuncture, and physical
herapy, despite their high use, are not well understood
n terms of their efﬁcacy in treating Mibyeong. Common
cupuncture and bee venom were the most frequent of
he acupuncture interventions, likely because it is gener-
lly used in KM clinics and hospitals. Healthy eating was
n important recommendation in patient education in treat-
ng Mibyeong, followed by promoting health environments
nd exercise. Eating well was ranked high because of its
ossible inﬂuence on stomach qi, which is the basal form
f qi that maintains that of the whole body. It could be
lso interpreted by the “Spleen dominates four extremi-
ies” theory, which means digestion malfunction results in
xhaustion, fatigue, and aversion to move using four limbs.9
xercise is considered good if tailored to a person’s constitu-
ion/condition. For example, a personwith qideﬁciency should
ot do hard exercise, which causes severe perspiration and
ence further loss of qi. Practitioners of Sasang constitution
edicine claim that each type of constitution has speciﬁc
xercises, and not using these exercises can result in poor
ealth.19
In this study, there are some limitations. First, KM
ractitioners responded relatively consistently for subtypes,
atterns, and interventions related to Mibyeong, but there is
till a lackof reliable and standardizeddiagnosis guidelines are
lso lacking. Second, we suggested many selections in ques-
ions, especially in patterns, herbal prescriptions, and herbs
o that there are scattered answers. Further research building
rom our results should seek to create a more detailed deﬁni-
ion of Mibyeong and assessments of the effectiveness of the
nterventions.
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